239 related articles for article (PubMed ID: 32213542)
41. ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.
Dunbier AK; Anderson H; Ghazoui Z; Lopez-Knowles E; Pancholi S; Ribas R; Drury S; Sidhu K; Leary A; Martin LA; Dowsett M
PLoS Genet; 2011 Apr; 7(4):e1001382. PubMed ID: 21552322
[TBL] [Abstract][Full Text] [Related]
42. Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
Zhang X; Zhang B; Zhang P; Lian L; Li L; Qiu Z; Qian K; Chen A; Liu Q; Jiang Y; Cui J; Qi B
PLoS One; 2019; 14(5):e0217181. PubMed ID: 31120927
[TBL] [Abstract][Full Text] [Related]
43. Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity.
Jia X; Li C; Li L; Liu X; Zhou L; Zhang W; Ni S; Lu Y; Chen L; Jeong LS; Yu J; Zhang Y; Zhang J; He S; Hu X; Sun H; Yu K; Liu G; Zhao H; Zhang Y; Jia L; Shao ZM
Clin Cancer Res; 2019 Jun; 25(12):3658-3672. PubMed ID: 30833270
[TBL] [Abstract][Full Text] [Related]
44. Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF.
Takayama KI; Suzuki T; Fujimura T; Yamada Y; Takahashi S; Homma Y; Suzuki Y; Inoue S
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10461-10466. PubMed ID: 28893982
[TBL] [Abstract][Full Text] [Related]
45. Loss of Estrogen-Regulated
Zhang W; Wu M; Chong QY; Zhang M; Zhang X; Hu L; Zhong Y; Qian P; Kong X; Tan S; Li G; Ding K; Lobie PE; Zhu T
Cancer Res; 2018 Sep; 78(17):4915-4928. PubMed ID: 29945962
[TBL] [Abstract][Full Text] [Related]
46. Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis.
Wu Y; Zhang Z; Cenciarini ME; Proietti CJ; Amasino M; Hong T; Yang M; Liao Y; Chiang HC; Kaklamani VG; Jeselsohn R; Vadlamudi RK; Huang TH; Li R; De Angelis C; Fu X; Elizalde PV; Schiff R; Brown M; Xu K
Cancer Res; 2018 Feb; 78(3):671-684. PubMed ID: 29212856
[TBL] [Abstract][Full Text] [Related]
47. SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells.
Yang H; Yu N; Xu J; Ding X; Deng W; Wu G; Li X; Hou Y; Liu Z; Zhao Y; Xue M; Yu S; Wang B; Li X; Niu G; Wang H; Zhu J; Zhuang T
J Exp Clin Cancer Res; 2018 Feb; 37(1):24. PubMed ID: 29433542
[TBL] [Abstract][Full Text] [Related]
48. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
[TBL] [Abstract][Full Text] [Related]
49. ERα-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization.
Wrobel K; Zhao YC; Kulkoyluoglu E; Chen KL; Hieronymi K; Holloway J; Li S; Ray T; Ray PS; Landesman Y; Lipka AE; Smith RL; Madak-Erdogan Z
Mol Endocrinol; 2016 Oct; 30(10):1029-1045. PubMed ID: 27533791
[TBL] [Abstract][Full Text] [Related]
50. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
Alfarsi LH; Ansari RE; Craze ML; Toss MS; Masisi B; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Dec; 178(3):535-544. PubMed ID: 31471836
[TBL] [Abstract][Full Text] [Related]
51. Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells.
Padró M; Louie RJ; Lananna BV; Krieg AJ; Timmerman LA; Chan DA
BMC Cancer; 2017 Mar; 17(1):203. PubMed ID: 28320353
[TBL] [Abstract][Full Text] [Related]
52. EGFR is a Therapeutic Target in Hormone Receptor-Positive Breast Cancer.
Jeong Y; Bae SY; You D; Jung SP; Choi HJ; Kim I; Lee SK; Yu J; Kim SW; Lee JE; Kim S; Nam SJ
Cell Physiol Biochem; 2019; 53(5):805-819. PubMed ID: 31670920
[TBL] [Abstract][Full Text] [Related]
53. MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.
Cui J; Yang Y; Li H; Leng Y; Qian K; Huang Q; Zhang C; Lu Z; Chen J; Sun T; Wu R; Sun Y; Song H; Wei X; Jing P; Yang X; Zhang C
Oncogene; 2015 Jul; 34(30):3895-907. PubMed ID: 25531331
[TBL] [Abstract][Full Text] [Related]
54. Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cells.
Su D; Fu X; Fan S; Wu X; Wang XX; Fu L; Dong XY; Ni JJ; Fu L; Zhu Z; Dong JT
Am J Pathol; 2012 Mar; 180(3):1189-1201. PubMed ID: 22341523
[TBL] [Abstract][Full Text] [Related]
55. ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance.
Xu Y; Huangyang P; Wang Y; Xue L; Devericks E; Nguyen HG; Yu X; Oses-Prieto JA; Burlingame AL; Miglani S; Goodarzi H; Ruggero D
Cell; 2021 Sep; 184(20):5215-5229.e17. PubMed ID: 34559986
[TBL] [Abstract][Full Text] [Related]
56. Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells.
Miah S; Bagu E; Goel R; Ogunbolude Y; Dai C; Ward A; Vizeacoumar FS; Davies G; Vizeacoumar FJ; Anderson D; Lukong KE
BMC Cancer; 2019 Jan; 19(1):78. PubMed ID: 30651078
[TBL] [Abstract][Full Text] [Related]
57. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells.
Honorat M; Mesnier A; Vendrell J; Guitton J; Bieche I; Lidereau R; Kruh GD; Dumontet C; Cohen P; Payen L
Endocr Relat Cancer; 2008 Mar; 15(1):125-38. PubMed ID: 18310281
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells.
Li Z; Levine KM; Bahreini A; Wang P; Chu D; Park BH; Oesterreich S; Lee AV
Endocrinology; 2018 Jan; 159(1):285-296. PubMed ID: 29029116
[TBL] [Abstract][Full Text] [Related]
59. Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression.
Zhu L; Li XX; Shi L; Wu J; Qian JY; Xia TS; Zhou WB; Sun X; Zhou XJ; Wei JF; Ding Q
Oncol Rep; 2019 Jan; 41(1):455-464. PubMed ID: 30542717
[TBL] [Abstract][Full Text] [Related]
60. Ligand-binding Domain-activating Mutations of ESR1 Rewire Cellular Metabolism of Breast Cancer Cells.
Zinger L; Merenbakh-Lamin K; Klein A; Elazar A; Journo S; Boldes T; Pasmanik-Chor M; Spitzer A; Rubinek T; Wolf I
Clin Cancer Res; 2019 May; 25(9):2900-2914. PubMed ID: 30733228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]